Skip to content
2000
Volume 6, Issue 11
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Adverse extracellular matrix (ECM) remodeling contributes to fibrotic disorders in the kidney, lung, and heart. Matrix metalloproteinases (MMPs) are key enzymes regulating ECM turnover, and MMP inhibition attenuates remodeling. Recent technological developments allow MMP-substrate relationships to be identified and explored as novel therapeutic targets. This review summarizes current and novel strategies to block MMP activity.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955706778742777
2006-11-01
2025-06-19
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955706778742777
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test